Integrating module
Anabolism — A Unified View
How the cell builds itself: energy budget, common precursors, reciprocal regulation, and a single pathway map linking gluconeogenesis, fatty-acid & cholesterol synthesis, amino-acid biosynthesis, nucleotide biosynthesis, and heme.
1. What is Anabolism?
Anabolism is the synthetic side of metabolism: the construction of complex biomolecules (carbohydrates, lipids, proteins, nucleic acids, cofactors, pigments) from simpler precursors. It is reductive, endergonic, and depends on a continuous supply of:
- Reducing power — mostly NADPH, occasionally NADH or FADH2.
- Activated carriers — ATP/GTP for phosphoryl transfer, acetyl-CoA for acyl groups, UDP-sugars for glycosyl groups, S-adenosyl-methionine (SAM) for methyl groups, PAPS for sulfate.
- Carbon skeletons — drawn from a small set of central metabolic intermediates (Section 3).
Catabolism (the destructive, oxidative, exergonic side) and anabolism are tightly coupled: catabolism produces the ATP and reducing equivalents that anabolism consumes, while sharing many of the same intermediates run in opposite directions through distinct enzymes — the principle of opposing irreversible stepsthat allows independent regulation.
2. Energy & Reducing-Equivalent Budget
Every anabolic pathway can be summarised by its “cost sheet” in ATP-equivalents and NADPH. The exchange rate \(\,2.5\,\text{ATP}\equiv 1\,\text{NADH}\,\) (and \(\sim 3\,\text{ATP}\equiv 1\,\text{NADPH}\) once transhydrogenase costs are folded in) lets us compare pathways on a single scale.
| Pathway | Net cost (per product) | Carbon source | Detailed page |
|---|---|---|---|
| Gluconeogenesis | 6 ATP + 2 NADH per glucose (from 2 pyruvate) | pyruvate, lactate, glycerol, glucogenic AAs | Part II |
| Glycogenesis | 2 ATP/UTP per glucose residue | glucose-6-P | Part II |
| Fatty-acid synthesis (palmitate) | 7 ATP + 14 NADPH per C16 | cytosolic acetyl-CoA (from citrate) | Part IV |
| Cholesterol synthesis | 18 acetyl-CoA + 36 ATP + 16 NADPH | acetyl-CoA | Part IV |
| Triacylglycerol assembly | ~7 ATP + glycerol-3-P + 3 fatty-acyl-CoA | glycerol-3-P, fatty-acyl-CoA | Part IV |
| De novo purine synthesis | 6 ATP per IMP (10 phosphoryl transfers) | PRPP, Gln, Gly, Asp, CO2, N10-formyl-THF | Part V |
| De novo pyrimidine synthesis | 3 ATP per UMP | carbamoyl-P, Asp, PRPP | Part V |
| Amino-acid biosynthesis (avg.) | 1–5 ATP + 0–2 NADPH per AA | α-KG, OAA, pyruvate, 3-PG, PEP, ribose-5-P | Part V |
| Heme synthesis | ~7 ATP per heme (8 ALA + Fe2+) | succinyl-CoA + glycine | Part V |
The dominant cell-wide consumer of NADPH is fatty-acid & cholesterol synthesis; the dominant cell-wide consumer of ATP for biosynthesis is protein synthesis(\(\sim 4\,\text{ATP}\) per peptide bond). Hexose monophosphate shunt and malic-enzyme cycling are the principal NADPH-generating modules.
3. The Twelve Universal Precursors
Almost every macromolecule in the cell traces its carbon backbone to one of twelve central intermediates produced by glycolysis, the pentose phosphate pathway, and the TCA cycle:
Glucose-6-P
glycogen, glycoproteins, NADPH (PPP)
Fructose-6-P
hexosamines, GlcNAc, glycosylation
Ribose-5-P
nucleotides, histidine, NAD/FAD/CoA
Erythrose-4-P
aromatic AAs (Phe/Tyr/Trp via shikimate, plants/microbes)
3-Phosphoglycerate
serine, glycine, cysteine, one-carbon pool
Phosphoenolpyruvate (PEP)
aromatic AAs, gluconeogenesis branch
Pyruvate
alanine, valine, leucine, gluconeogenic anaplerosis
Acetyl-CoA
fatty acids, cholesterol, ketone bodies, acetylation
α-Ketoglutarate
glutamate, glutamine, proline, arginine, polyamines
Succinyl-CoA
heme, porphyrins, ketone-body uptake
Oxaloacetate
aspartate, asparagine, pyrimidines, gluconeogenesis
Glycerol-3-P
triacylglycerols, phospholipids
These twelve nodes are the topological centre of metabolism. Anabolic regulation largely amounts to controlling the partitioning of carbon at these branch points (e.g. citrate → cytosolic acetyl-CoA vs. continued TCA flux; glucose-6-P → PPP vs. glycolysis).
4. Anabolic Pathways at a Glance
The cell’s biosynthetic activity organises into seven major anabolic modules. Each is detailed in the indicated sub-page; this section is the integrating overview.
A. Carbohydrate anabolism
Gluconeogenesis (liver/kidney) reverses glycolysis at three irreversible steps via PC, PEPCK, F1,6BPase, G6Pase. Glycogenesis (liver/muscle) condenses glucose-1-P (UDP-glucose) onto glycogen via glycogen synthase + branching enzyme. The pentose phosphate pathway branches off glucose-6-P to produce NADPH and ribose-5-P.→ Part II
B. Fatty-acid & lipid anabolism
De novo fatty-acid synthesis (cytosolic FAS, multidomain dimer) iteratively adds malonyl-CoA to a growing acyl-ACP, consuming 2 NADPH per cycle. Triacylglycerol assembly via glycerol-3-P, monoacyl-glycerol pathway in enterocytes. Phospholipids via CDP-DAG / Kennedy pathway. Cholesterol synthesis (HMG-CoA reductase, the statin target) builds 27-C from 18 acetyl-CoA via mevalonate → isoprenoids → squalene → lanosterol. Steroid hormones derive from cholesterol (CYP-mediated).→ Part IV
C. Amino-acid biosynthesis
Eleven of twenty proteinogenic AAs are synthesised in humans (the “non-essential” set), grouped by carbon-skeleton family: α-KG family (Glu, Gln, Pro, Arg), OAA family (Asp, Asn), 3-PG family (Ser, Gly, Cys), pyruvate family (Ala), and via specialised one-step transaminations (Tyr from Phe). Nitrogen enters via glutamate dehydrogenase / glutamine synthetase.→ Part V
D. Nucleotide biosynthesis
Purines (de novo): IMP assembled stepwise on PRPP from Gly, Asp, Gln, CO2, formate (10 enzymatic steps); diverges to AMP & GMP. Pyrimidines: ring built first (carbamoyl-P + Asp → orotate), then attached to PRPP → UMP → CTP/dCTP/TTP. Salvage pathways (HGPRT, APRT) recycle bases — deficiency causes Lesch-Nyhan. Ribonucleotide reductase generates dNTPs.→ Part V
E. Heme & porphyrin synthesis
Eight ALA molecules (succinyl-CoA + glycine; ALA synthase, mitochondrial) condense via porphobilinogen to uroporphyrinogen-III, decarboxylated and oxidised to protoporphyrin-IX, then iron is inserted by ferrochelatase. Defects cause the porphyrias; lead poisoning inhibits ALA dehydratase & ferrochelatase.
F. Glycoconjugate & complex-carbohydrate anabolism
N- and O-linked glycosylation in ER/Golgi, GAG/proteoglycan synthesis, hexosamine biosynthetic pathway (HBP) feeding O-GlcNAc signalling. Activated sugars: UDP-glucose, UDP-Gal, UDP-GlcNAc, GDP-Man, GDP-Fuc, CMP-NeuAc.
G. Cofactor & coenzyme anabolism
Coenzyme A (from pantothenate, Cys, ATP), NAD+/NADP+ (from niacin or de novo from Trp via kynurenine), FAD/FMN (from riboflavin), THF (from folate), TPP (from thiamine), pyridoxal-P (from B6), biotin/lipoate covalent attachment, ubiquinone (Q10) from tyrosine + isoprenoids.
5. Compartmentalization
Anabolism and catabolism share intermediates but are physically separated by membrane compartments, allowing simultaneous, opposed flux without futile cycling.
| Compartment | Anabolic processes housed | Major shuttles in/out |
|---|---|---|
| Cytosol | FA synthesis, cholesterol (early), nucleotide synthesis, glycolysis-reversed steps, PPP | citrate-malate-pyruvate cycle (acetyl-CoA out of mito); NADPH from PPP & malic enzyme |
| Mitochondrial matrix | Heme synthesis (1st & last steps), urea cycle (1st 2 steps), pyruvate carboxylation (gluconeogenesis seed), FA elongation (specialised) | citrate carrier, malate-aspartate shuttle, glycerol-3-P shuttle |
| Endoplasmic reticulum | FA elongation & desaturation, TAG & phospholipid assembly, cholesterol later steps, glycoprotein N-glycosylation start | SREBP-2 cholesterol-sensing platform |
| Peroxisome | Plasmalogen synthesis (ether lipids), bile-acid & very-long-chain FA processing | PEX import machinery |
| Golgi | Glycan elaboration, GAG & proteoglycan synthesis, sphingolipid head-group attachment | nucleotide-sugar transporters |
| Nucleus | dNTP balance maintenance for DNA synthesis (R2-RNR localisation) | nuclear-pore-mediated nucleotide flux |
The citrate–malate–pyruvate cycle is the canonical example: mitochondrial citrate exits to the cytosol, ATP-citrate lyase splits it back to oxaloacetate + acetyl-CoA, the OAA returns as malate (or as pyruvate via malic enzyme, generating cytosolic NADPH). This single mechanism funds both fatty-acid synthesis and the NADPH it requires.
6. Reciprocal Regulation with Catabolism
At every branch point where a forward (catabolic) and reverse (anabolic) pathway diverge, regulation is reciprocal: signals that activate one inhibit the other. The key control nodes:
| Branch point | Catabolic enzyme | Anabolic enzyme | Reciprocal regulator |
|---|---|---|---|
| F-6-P / F-1,6-BP | PFK-1 (glycolysis) | F-1,6-BPase (gluconeogenesis) | F-2,6-BP (PFK-2/FBPase-2 bifunctional, hormone-regulated) |
| Pyruvate / OAA | PDH (entry to TCA) | PC + PEPCK (gluconeogenesis seed) | acetyl-CoA, NADH activate PC and inhibit PDH |
| Acetyl-CoA / malonyl-CoA | CPT-I (FA oxidation entry) | ACC (FA synthesis) | malonyl-CoA inhibits CPT-I; AMPK phosphorylates & inactivates ACC |
| Glycogen | glycogen phosphorylase | glycogen synthase | PKA / PP1 phosphorylation cascade (glucagon vs. insulin) |
| Cholesterol | (HSL releasing FAs) | HMG-CoA reductase | SREBP-2 transcription, INSIG/SCAP cholesterol sensor, AMPK phosphorylation |
The bifunctional enzyme PFK-2/FBPase-2 deserves special note: it is regulated by glucagon-driven PKA phosphorylation (which switches its activity from kinase to phosphatase, depleting F-2,6-BP, thereby inhibiting PFK-1 and activating F-1,6-BPase). A single phosphorylation event flips the entire glycolysis/gluconeogenesis balance.
7. Hormonal & Nutrient Sensing
Insulin (anabolic master signal)
Activates PI3K-Akt → mTORC1, promotes glycogenesis (PP1 dephosphorylates GS), lipogenesis (SREBP-1c, ACC), protein synthesis (4E-BP1/S6K1). Suppresses gluconeogenesis (FoxO export) and lipolysis (HSL inactivation).
Glucagon / catecholamines (catabolic)
Drive cAMP-PKA cascade. Activate glycogenolysis, gluconeogenesis (CREB → PEPCK, G6Pase), lipolysis. Inhibit anabolic enzymes (ACC, GS) by phosphorylation.
AMPK (low-energy sensor)
Activated by AMP/ATP ratio (energy stress). Phosphorylates and inactivates ACC, HMG-CoA reductase, glycogen synthase — a global brake on anabolism. Also inhibits mTORC1 (via TSC2/Raptor) and activates ULK1 (autophagy).
mTORC1 (nutrient/growth sensor)
Integrates amino-acid availability (Rag GTPases on lysosome), insulin/Akt, energy (AMPK), oxygen. Drives protein synthesis (4E-BP1, S6K1), lipid synthesis (SREBP), nucleotide synthesis (S6K1 → CAD), and represses autophagy.
SREBP-1c / SREBP-2 (lipid sensors)
Membrane-bound transcription factors cleaved when sterols are low. SREBP-1c drives FA synthesis (ACC, FAS, SCD1); SREBP-2 drives cholesterol synthesis (HMGCR, LDL-R). Insulin / mTORC1 both upregulate SREBP-1c.
ChREBP (carbohydrate sensor)
Activated by xylulose-5-P (PPP intermediate, signalling glucose excess). Drives lipogenic gene transcription (FAS, ACC, L-PK, SCD1) in parallel with SREBP-1c.
Net effect: anabolic flux is “on” only when nutrient supply, energy charge, and growth signals concur. Loss of any one input redirects flux towards catabolism / autophagy.
8. Disease & Pharmacology of Anabolism
Cancer (Warburg + lipogenic switch)
Tumours upregulate aerobic glycolysis (Warburg) and de novo lipogenesis to fuel membrane biosynthesis; ACC, FAS, ATP-citrate lyase are validated targets.
Statins (HMGCR inhibitors)
Block cholesterol synthesis at the rate-limiting step; trigger SREBP-2 induction of LDL-R and lower plasma LDL.
Methotrexate (DHFR inhibitor)
Blocks THF regeneration, starving thymidylate & purine synthesis — rapidly dividing cells most affected.
5-FU, 6-MP (nucleotide-synthesis blockers)
5-fluorouracil traps thymidylate synthase; 6-mercaptopurine inhibits purine de novo & salvage.
Type 2 diabetes
Insulin resistance disinhibits hepatic gluconeogenesis (high fasting glucose) while paradoxically preserving lipogenesis — selective insulin resistance.
Porphyrias
Defects in heme-synthesis enzymes accumulate porphyrin precursors; clinical presentation depends on which step (acute vs. cutaneous types).
Glycogen-storage diseases
Defects in glycogen anabolism (glycogen synthase, branching enzyme) or catabolism (G6Pase, debranching enzyme, lysosomal α-glucosidase).
Lesch-Nyhan
HGPRT deficiency → loss of purine salvage, compensatory de novo overdrive, hyperuricemia, neurologic symptoms.
9. Further Reading & Detailed Pages
- Part II — Carbohydrate Metabolism: gluconeogenesis, glycogenesis, PPP, fructose & galactose handling.
- Part IV — Lipid Metabolism: fatty-acid synthesis, TAG & phospholipid assembly, cholesterol, ketogenesis.
- Part V — Amino Acid & Nucleotide Metabolism: amino-acid biosynthesis families, urea cycle, purine/pyrimidine synthesis, heme.
- Part VI — Integration & Regulation: organ-specific metabolism, fed/fasting states, exercise, hormonal control.
- Biochemistry course: structural & mechanistic depth on the enzymes listed above.
- Cell Physiology — Energetics: catabolic counterpart (TCA, ETC, ATP synthase) that provides the ATP/NADH/NADPH budget consumed here.
- Plant Biochemistry: photosynthetic anabolism (Calvin cycle, sucrose/starch synthesis, secondary metabolism).